Milestone Pharmaceuticals to Report Q2 Results on August 12
MIST Milestone Pharmaceuticals Inc
$1.25 -0.40%
View chart & analysis → - 1Milestone Pharmaceuticals (MIST) will report its second-quarter results on August 12, 2026.
- 2The Q2 consensus calls for revenue of $820,000 and a loss per share of -$0.19.
- 3The annual revenue estimate has been cut over the past 90 days from $37.96 million to $5.39 million.
This 3-line summary is compiled from the report below.
GuruFocus.com +2 View original ↗🎯 오늘의 AI 픽 5종목, 무료로 전부 공개합니다
숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다